Your browser doesn't support javascript.
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters.
Mohandas, Sreelekshmy; Yadav, Pragya Dhruv; Shete, Anita; Nyayanit, Dimpal; Sapkal, Gajanan; Lole, Kavita; Gupta, Nivedita.
  • Mohandas S; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Shete A; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Nyayanit D; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Sapkal G; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Lole K; Indian Council of Medical Research-National Institute of Virology, Pune 411021, India.
  • Gupta N; Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi 110029, India.
Viruses ; 13(9)2021 09 05.
Article in English | MEDLINE | ID: covidwho-1390794
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals Language: English Year: 2021 Document Type: Article Affiliation country: V13091773

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals Language: English Year: 2021 Document Type: Article Affiliation country: V13091773